Materna Medical Completes First Close of Series B2 Financing Round
Materna Medical, Inc., a leading innovator in women's pelvic health solutions, has announced the completion of the first close of a $20 million Series B2 financing round.
- Materna Medical, Inc., a leading innovator in women's pelvic health solutions, has announced the completion of the first close of a $20 million Series B2 financing round.
- "Materna is a first mover, aiming to transform the standard of care in labor and delivery.
- Imagine a world in which women aren’t injured while delivering vaginally," commented Tracy MacNeal, Chief Executive Officer for Materna Medical.
- The funds from Series B2 will be used to obtain FDA marketing authorization for Materna Prep and support the commercial launch of this transformative technology.”
For more information on Materna Medical, visit MaternaMedical.com .